RE: 150 PLUS TODAY8 Oct 2020 09:51
An update on clinical trials saw shares in 4D Pharma [LON:DDDD] slump in Wednesday, shedding 30% by the close. Despite the headline results seeming to be positive, investors had clearly expected more and heavy selling saw the shares lose the gains accrued over the last six weeks. UPDATE WAS POSITIVE ...